The application of artificial intelligence is the research focus of start-up company Insilico Medicine. The medical technology company is developing artificial intelligence algorithms to study the ageing processes. The aim is to find new interventions in aging.InSilico Medicine develops knowledge management system of annotated drugs and small molecules. The company foremost develops drugs for oncology and aging, based on a patient's gene expression data. InSilico Medicine is based in Baltimore, Maryland, U.S. Last year the company launched Aging.AI 2.0, which is a blood biochemistry predictor of human age. This built on the success of its Aging.AI 1.0 platform. Version 1.0 succeeded in using just 41 blood biochemistry biomarkers to test thousands of people. Through this type of analysis Insilico Medicine becames the first company to apply deep generative adversarial networks (GANs) to generating anti-cancer new molecules.

Artificial molecules.

Physics.org

Elderly Cubans wait for help at La Milagrosa Grandparent House in Havana

Adalberto Roque, AFP

Excerpt from:
Artificial intelligence targets human age-reversal - Digital Journal